LVM Capital Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

LVM Capital Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-7,685	Closed	-$477K	–	127
2016 Q3	$477K	Buy	+7,685	New	+$461K	0.15%	67
2015 Q1	–	Sell	-7,140	Closed	-$459K	–	116
2014 Q4	$459K	Sell	7,140 -505	-7%	-$32.2K	0.15%	67
2014 Q3	$486K	Sell	7,645 -40	-0.5%	-$2.48K	0.16%	66
2014 Q2	$477K	Buy	7,685 +50	+0.7%	+$2.97K	0.15%	67
2014 Q1	$446K	Buy	7,635 +350	+5%	+$19.8K	0.16%	67
2013 Q4	$387K	Buy	7,285 +440	+6%	+$22.3K	0.14%	79
2013 Q3	$327K	Buy	6,845 +100	+1%	+$4.74K	0.12%	82
2013 Q2	$307K	Buy	+6,745	New	+$312K	0.12%	88

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Colrain Capital Boston, Massachusetts $259M AUM 63.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SCM

Stuyvesant Capital Management Armonk, New York $41.1M AUM 17.11% 1-Year Est. Return

LVM Capital Management's PPH Position: Q4 2016 in Review

LVM Capital Management sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2016, closing a stake of 7,685 shares — an estimated $477K sold.

LVM Capital Management first reported a position in PPH in Q2 2013 and held it in 8 quarters. The position peaked at $486K in Q3 2014. 51 funds tracked by Wall St. Rank hold PPH as of Q4 2016.

LVM Capital Management reported no remaining VanEck Pharmaceutical ETF position as of Q4 2016 after selling out during the quarter.
LVM Capital Management sold 7,685 VanEck Pharmaceutical ETF shares in Q4 2016, an estimated $477K.
LVM Capital Management first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and held it in 8 quarters.
LVM Capital Management's VanEck Pharmaceutical ETF position peaked at $486K in Q3 2014.
51 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2016.

Based on LVM Capital Management's 13F filing for Q4 2016, filed 9 Jan 2017.